Protara Therapeutics TARA
NASDAQ TARA
$3.05 -0.16 (-4.98%)
At close: Sep 30, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Debt Ratio (2013 - 2020)

Updated

Protara Therapeutics' Debt Ratio was 0.00 in Q3 2020, down 87.3% from the prior quarter.

Analysis

Protara Therapeutics (TARA) Debt Ratio (2013 - 2020) Analysis & Trends

For FY2013, Debt Ratio at Protara Therapeutics came in at 0.66.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Protara Therapeutics 189.66 Mn 189.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 0.00
Jun 30, 2020 0.01
Mar 31, 2020 0.02
Dec 31, 2013 0.66
API Access

Protara Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TARA&period=max&api_key=YOUR_API_KEY